Johnson & Johnson (NY:JNJ)

256.03 UNCHANGED

Delayed Quote Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

99 100 Next >

The Industrial Giant's Resurgence: Why 3M (NYSE: MMM) Is Poised to Outperform the S&P 500 Over the Next Decade

October 20, 2025

After a decade of significant underperformance, marked by legal battles and strategic drift, industrial conglomerate 3M Company (NYSE: MMM) is now making aggressive moves to reclaim its former glory....

Via MarketMinute

Q3 2025 Earnings Season: A High-Stakes Quarter for Market Direction

October 20, 2025

The stage is set, and the curtains are about to rise on the Q3 2025 earnings season, a period historically known to inject both volatility and direction into the financial markets. As investors brace...

Via MarketMinute

Topics Artificial Intelligence Earnings Economy

Kenvue Stock Climbs Premarket, Day After Record Slide On UK Lawsuit: Retail Bulls Remain Unshaken ↗

October 17, 2025

Via Stocktwits

Global Trade Tensions: A Rollercoaster Ride for the Stock Market in October 2025

October 20, 2025

October 2025 has proven to be a turbulent month for global financial markets, as the persistent shadow of trade tensions and tariffs, particularly between the United States and China, continues to...

Via MarketMinute

Topics Economy Electric Vehicles Government

3 Dividend Stocks With 5% (or Higher) Yields to Buy Hand Over Fist in October ↗

October 20, 2025

These three stocks have elevated yields and attractive dividend histories.

Via The Motley Fool

2 Top Dividend Kings Every Income Investor Should Own ↗

October 20, 2025

These companies pay durable and steadily rising dividends.

Via The Motley Fool

Topics Bonds

Biotech Boom: Strategic Realignments and AI Integration Fuel Investor Focus, Signaling Broader Market Shifts

October 19, 2025

The biotechnology sector is currently experiencing a significant surge in investor attention, characterized by a blend of cautious optimism and strategic focus. As of October 2025, this heightened...

Via MarketMinute

Topics Artificial Intelligence ETFs Economy

Global Economic Headwinds Intensify as China's Q3 GDP Forecast Signals Year-Low Growth, Sending Ripples Through International Markets

October 19, 2025

The global economy is bracing for a significant deceleration in 2025, a trend intensified by persistent trade tensions and widespread policy uncertainties. At the heart of this growing fragility lies...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

Meet the 5%-Yielding Dividend Stock That Could Soar in 2026 ↗

October 19, 2025

Kenvue could start to recover in 2026.

Via The Motley Fool

Johnson & Johnson's M&A Strategy Is the Real Story for Investors ↗

October 18, 2025

Johnson & Johnson’s rumored Protagonist buyout demonstrates its proven M&A strategy: divesting low-growth units to fund high-margin, innovative assets.

Via MarketBeat

Why Kenvue Stock Tumbled by 13% on Thursday ↗

October 16, 2025

The company's baby powder product is under legal fire once again.

Via The Motley Fool

Topics Lawsuit

Global Markets Brace for Impact as Investor Risk Aversion Escalates Amidst Geopolitical Tensions and Economic Headwinds

October 16, 2025

Global financial markets are currently navigating a treacherous landscape marked by a pronounced surge in investor risk aversion. As of October 16, 2025, a potent cocktail of persistent geopolitical...

Via MarketMinute

Topics Bonds Economy World Trade

Global Markets Brace for Turbulence: Credit Concerns and Geopolitical Tensions Fuel Volatility

October 16, 2025

Global financial markets are currently gripped by a palpable sense of unease and heightened volatility as October 2025 unfolds. A complex interplay of escalating geopolitical tensions, persistent...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

Kenvue's Dual Dilemma: Tylenol and Talc Fears Trigger Sector Jitters

October 16, 2025

New York, NY – October 16, 2025 – The Consumer Staples and Healthcare sectors of the S&P 500 are experiencing a notable day of underperformance, largely overshadowed by the precipitous stock plunge of...

Via MarketMinute

Topics Death Government Lawsuit

Fed Signals Further Easing Amid Uneven Inflation and Softening Labor Market: SF FedViews Points to More Rate Cuts

October 16, 2025

The Federal Reserve Bank of San Francisco's latest "SF FedViews" publication, released on October 16, 2025, offers a nuanced picture of the U.S. economy, highlighting inconsistent progress on inflation...

Via MarketMinute

Topics Artificial Intelligence Bonds Credit Cards

Johnson & Johnson Plunges Amidst Escalating Talc Litigation: Billions at Stake as Legal Battles Intensify

October 16, 2025

New York, NY – October 16, 2025 – Johnson & Johnson (NYSE: JNJ), once considered a stalwart of stability, is currently navigating turbulent waters, finding itself among the market's bottom performers...

Via MarketMinute

Topics Bankruptcy Death Lawsuit

Kenvue (KVUE) Plunges Amidst Dual Headwinds: Tylenol Fears and Escalating Talc Litigation

October 16, 2025

Kenvue (NYSE: KVUE), the consumer health giant spun off from Johnson & Johnson, has found itself at the bottom of today's market performance, with its stock price experiencing a significant decline. As...

Via MarketMinute

Topics Government Lawsuit

Investors Retreat to Safety: US Fund Flows Signal Defensive Stance Amidst Market Uncertainty

October 16, 2025

As October 2025 progresses, a palpable shift in investor sentiment is evident across US financial markets, with recent fund flow data signaling a clear pivot towards defensive strategies. Faced with...

Via MarketMinute

Topics Bonds Economy

Johnson & Johnson Reports Strong Phase 3 Results For Multiple Myeloma Therapy ↗

October 16, 2025

Tecvayli combined with Darzalex Faspro improves overall survival in relapsed/refractory multiple myeloma, Johnson & Johnson reports.

Via Benzinga

Johnson & Johnson: Earnings Beat, High Technical Momentum, UK Talc Suits Loom ↗

October 16, 2025

Johnson & Johnson's stock shows strong technical momentum following a modest earnings beat, but faces potential volatility due to ongoing UK talc lawsuits and a strategic orthopedics spinoff.

Via Talk Markets

Topics Earnings Lawsuit

Jamison Loads Up on Johnson & Johnson (JNJ) Stock With a 39K Share Purchase ↗

October 16, 2025

Via The Motley Fool

Topics Regulatory Compliance

Johnson & Johnson, Kenvue Named In First Ever UK Legal Action Over Talc Cancer Claims ↗

October 16, 2025

Johnson & Johnson faces 3,000 UK lawsuits alleging asbestos-contaminated talcum powder caused cancer and concealed risks for decades.

Via Benzinga

Topics Lawsuit

Johnson & Johnson Reportedly Faces Major UK Lawsuit Over Baby Powder Cancer Risks ↗

October 16, 2025

A legal claim involving 3,000 people has been reportedly filed against Johnson & Johnson (NYSE: JNJ) in the U.K., alleging that the company knowingly sold asbestos-contaminated baby powder.

Via Benzinga

Topics Lawsuit

Scott Bessent Says US Investment Boom 'Sustainable' Under Trump: 'The Only Thing Slowing Us Down...' ↗

October 16, 2025

U.S. Treasury Secretary Scott Bessent credited the country's investment boom to President Donald Trump's policies on Wednesday, and expressed optimism about its sustainability, but said the government...

Via Benzinga

Topics Government

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever. ↗

October 16, 2025

Investors should be able to count on these stocks to deliver steady and growing income over the long term.

Via The Motley Fool

Johnson & Johnson Battles New UK Talc Cancer Claims Worth £1B After Massive US Verdict: Report ↗

October 15, 2025

Meanwhile, analysts raised price targets on the stock following strong Q3 results and the planned orthopedic spin-off.

Via Stocktwits

Topics Bankruptcy Death Lawsuit

Dow Jones Stumbles with Fractional Dip, Signaling Cautious Market Sentiment Amidst Global Headwinds

October 15, 2025

New York, NY – October 15, 2025 – The Dow Jones Industrial Average (DJIA) experienced a fractional dip today, reflecting a palpable sense of caution pervading market sentiment. While other major...

Via MarketMinute

Topics Artificial Intelligence Economy Government

Dow Jones Stumbles Amidst Global Headwinds, Reflecting Cautious Market Sentiment

October 15, 2025

The Dow Jones Industrial Average (DJIA) concluded a volatile trading day on Wednesday, October 15, 2025, with a fractional dip, signaling a cautious, if not overtly negative, sentiment pervading the...

Via MarketMinute

Topics Artificial Intelligence Bonds Climate Change

Dividend Defenders: How Two Stalwart Stocks Weathered April's Market Squall

October 15, 2025

As the calendar turned to April 2025, financial markets found themselves in a precarious position, teetering on the brink of a full-blown bear market. Investor fears, fueled by persistent inflation,...

Via MarketMinute

Topics Bonds Economy Energy

Dividend Duo Delights Investors: Meta Platforms and Johnson & Johnson Shine in 2025

October 15, 2025

In a year marked by evolving market dynamics and a persistent search for both growth and stability, two distinct titans of industry—Meta Platforms (NASDAQ: META) and Johnson & Johnson (NYSE: JNJ)—have...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.